|
FY2022
12 months to Dec 31, 2022
|
FY2021
10 months to Dec 31, 2021
|
|
|---|---|---|
| Net income | ||
| Adjustments to reconcile net loss to net cash used in operating activities: | ||
| Interest earned on marketable securities used in operating activities | ||
| Change in fair value of derivative warrant liabilities | ||
| Offering costs associated with derivative warrant liabilities | ||
| Dividend income earned on marketable securities held in Trust Account | ||
| Changes in operating assets and liabilities: | ||
| Prepaid expenses | ||
| Accrued expenses | ||
| Income tax payable | ||
| Franchise tax payable | ||
| Net cash used in operating activities | ||
| Cash Flows from Investing Activities | ||
| Purchases of marketable securities in Trust Account | ||
| Withdrawal from Investment held in trust account to pay taxes | ||
| Net cash (provided by) used in investing activities | ||
| Cash Flows from Financing Activities | ||
| Proceeds from note payable | ||
| Proceeds from issuance of Class B common stock to Sponsor | ||
| Proceeds from Sponsor note | ||
| Repayment of Sponsor note | ||
| Proceeds received from initial public offering, gross | ||
| Proceeds received from private placement | ||
| Offering costs paid | ||
| Net cash provided by financing activities | ||
| Net increase in Cash | ||
| Net (decrease) increase in cash | ||
| Cash - Beginning of period | ||
| Cash - End of period | ||
| Supplemental disclosures of non-cash activities: | ||
| Offering costs included in accrued offering costs | ||
| Deferred underwriting commissions | ||
| Accretion of Class A common stock subject to possible redemption | ||
| Deemed dividend to Class A stockholders |
Loading...
